
Pharmaceutical professionals conduct quality-control work at an Indian bioequivalence research facility.

Pharmaceutical professionals conduct quality-control work at an Indian bioequivalence research facility.

A premium healthcare corporate visual representing increased promoter investment in a major hospital and healthcare network.

A pharmaceutical research and healthcare setting representing Sun Pharma's agreement with the US government.

India opens the second call under its ₹5,000-crore PRIP Scheme to support pharmaceutical and MedTech research, startups and advanced healthcare innovation.

Ophthalmic eye drops and advanced vision-care technology representing Lupin and Tenpoint Therapeutics' licensing partnership for the presbyopia treatment YUVEZZI.

Insulin pens and pharmaceutical research imagery representing Mankind Pharma's licensing partnership with Chongqing Chenan Biopharmaceutical for diabetes therapies in India.

PM Modi calls for Indian pharmaceutical companies to enter the global top five.

FSSAI inspectors examining health supplement products inside a modern pharmaceutical manufacturing facility during a regulatory compliance inspection.

FSSAI officials inspecting a packaged drinking water plant with rusted RO equipment and unhygienic production conditions leading to licence suspension.

Food safety inspectors examine rusted RO tanks and unhygienic conditions inside a packaged drinking water factory after FSSAI suspended the licence over serious safety violations.
India Business & Trade is a national media platform decoding the ideas, decisions and shifts shaping India’s growth story—across plicy, business, global commerce and a rapidly evolving marketplace.
India Business & Trade
M-62, Saket, New Delhi-110064, India
Stay ahead in the dynamic world of trade and commerce with India Business & Trade’s weekly newsletter.
Copyright © 2026 India Business & Trade. All Rights Reserved